 |
Energy Fuels and Hyperion Sign MOU for the Supply of Monazite to Produce Rare Earth ProductsEnergy Fuels announced the execution of a non-binding memorandum of understanding for the supply of natural monazite sands from Hyperion’s Titan Project in Tennessee Research, News & Market Data on Energy Fuels |
 |
CanAlaska Completes Initial Drilling at WaterburyCanAlaska Uranium announced that it has curtailed winter drilling on its 100%-owned Waterbury uranium project |
 |
Ocugen Shares Positive Results of the Second Interim Analysis of Phase 3 Study of COVAXINOcugen announced that its co-development partner, Bharat Biotech, shared positive results of the second interim analysis of its Phase 3 study of COVAXIN, a whole virion inactivated COVID-19 vaccine candidate Research, News & Market Data on Ocugen |
 |
ISG Adds Real-Time Data Feeds To Its Vendor Compliance And Risk Management PlatformInformation Services Group announced that it is adding real-time data feeds to its market-leading ISG GovernX® vendor compliance and risk management platform Research, News & Market Data on ISG |
 |
Gevo to Report First Quarter 2021 Financial Results on May 13, 2021Gevo, Inc. announced that it will host a conference call on Thursday, May 13, 2021 at 4:30 p.m. EDT to report its financial results for the first quarter ended March 31, 2021 Research, News & Market Data on Gevo |
 |
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102Ayala Pharmaceuticals announced the dosing of the first patient in the ongoing Phase 1 clinical trial evaluating its potent investigational gamma secretase inhibitor (GSI), AL102, in combination with Novartis’ investigational anti-B-cell maturation antigen (BCMA) agent, WVT078 Research, News & Market Data on Ayala Pharmaceuticals |
 |
Kratos Awarded Approximately $30 Million to Support Space-Related National Security EffortsKratos Defense & Security announced that it had received more than $30 million to support space-related U.S. national security efforts |
Stay up to date. Follow us:
 |
 |
 |
 |
 |
 |
